Disclosure: La Petite Labs publishes this review and sells its own pet supplements.
What has been corrected
Correction notice — 11 November 2026: the earlier review omitted Nutramax’s May 26, 2022 disclosure of a UL-administered GMP assessment and wrongly implied that the relevant clinical evidence was inaccessible to consumers. We have corrected those statements, added public research references, narrowed claims about COA access and removed unsupported blanket claims about experts and catalogue-wide disclosures. The revised score is 74.5/100 under the published criteria.
Labels must be matched to the exact product
The reviewed Cosequin with MSM tablet, Dasuquin with MSM soft chews, Dasuquin Senior soft chews and Welactin Advanced 3TA liquid publish quantities. The panels differ by product and, for Dasuquin, size variant. Senior’s total-only blend is a specific limitation, not an absence of quantities. The linked product comparisons preserve units and qualifications such as ASU powder standardization.
Quality systems include a disclosed independent audit
Nutramax describes internal raw-material and finished-product testing. A May 26, 2022 company announcement reports an independent GMP conformance assessment administered by UL. That announcement documents the audit reported then; it does not establish current certificate validity or identify the analytical laboratory for any particular finished-product lot.
What public batch documentation tells us
The product and quality sources linked here did not provide a public, lot-matched finished-product certificate of analysis for us to inspect in this review. That limits this review of batch documentation; it is not evidence that Nutramax does not test, that a certificate does not exist, or that another product is safer.
Research is not confined to a professional portal
Public research can be read without a Nutramax professional login. For example, Hart and colleagues (2012) evaluated Proviable-DC in 53 cats with chronic diarrhea over 21 days. Owners reported firmer stools, but this was an open-label study without a placebo control. It establishes the existence of accessible product-specific research; it does not prove all claims for all Proviable formulations.
Clinical evidence needs formulation and outcome context
Public product research includes Kampa et al. (2023), a trial conducted in 2018–2020 with 75 dogs in the final analysis. It identifies Dasuquin with MSM, but the described preparation has not been verified as equivalent to today’s expanded label. Its Dasuquin group did not show significant improvement from baseline in peak vertical force at weeks 4 or 6. The authors identify the short duration as a limitation and note that longer use could differ. The corrigendum identifies Pharmalink International as funder. This is neither a trial of Hollywood Elixir nor proof that current Dasuquin is ineffective.
What remains outside this review
This is a dated review of the named public sources, not a complete audit of Nutramax’s catalogue, personnel, facilities or certificate history. We do not infer that no qualified scientists exist because one page does not identify a formulator. A company’s historical audit announcement also does not establish current certification for every facility.
Transparency score status
The revised public-disclosure score is 74.5/100, calculated from all eight published criteria. The dated source sample and criterion reasons are recorded in the report dataset. This score is not a safety or effectiveness rating.
Where La Petite Labs fits
A joint-support product, a liver-support product, a probiotic and an omega-3 product serve different purposes. Our separate comparisons discuss specific formulations; this brand review does not recommend a La Petite Labs replacement for a veterinarian-directed Nutramax product. La Petite Labs’ labels and benefit claims require the same scrutiny.
What a buyer can do next
Confirm the exact product and animal species, read the serving directions and ingredient units, and ask your veterinarian how the relevant evidence applies to your pet. If batch documentation matters to the decision, ask the manufacturer for an appropriate lot-specific report and inspect its scope. Personal reviews and veterinarian-recommendation surveys answer different questions from controlled efficacy studies.
Updated disclosure score
74.5/100 under the published rubric.
Nutramax scores 74.5/100 under the existing public-disclosure rubric. The reviewed core product families publish substantial label and manufacturing information, named veterinary leadership and specific testing processes. Public research exists; citation placement and batch-result access remain less complete.
Criterion scores and reasons
| Criterion | Score | Weight | Evidence and limits |
|---|---|---|---|
| label dose transparency | 8/10 | 15 | The sampled Cosequin MSM tablet, Dasuquin MSM soft chews, Denamarin chewable tablet and Welactin Advanced 3TA liquid publish named active amounts and serving directions. Proviable-DC identifies seven strains but guarantees their combined CFU count. Dasuquin Senior provides individual core amounts and a separately named three-ingredient blend total. This is a five-family representative sample with Senior as a variation check, not a census of every Nutramax SKU. ASU values are standardized powder amounts; EPA+DHA totals are not separate EPA/DHA amounts. |
| scientific rationale disclosure | 7/10 | 10 | Denamarin explains SAMe, glutathione and silybin with references; Dasuquin explains cartilage roles and its ingredient combination; Proviable explains the different roles of probiotics and prebiotics. Explanations on the sampled Cosequin and Welactin pages are shorter and predominantly benefit-oriented. The score describes the consistency of public explanations, not whether the ingredients work or every mechanism is clinically established at the supplied dose. |
| evidence clinical citation transparency | 6/10 | 15 | Denamarin publishes author/journal references linked to public records. The reviewed Proviable and Dasuquin product pages use research language without consistently placing full study identification next to the claim. Public journal papers on Proviable-DC and Dasuquin with MSM are accessible outside the professional portal. Those papers do not establish every claim, all six advertised Proviable studies, all current formulas or Dasuquin Senior outcomes. External discoverability corrects the old all-evidence-gated implication; it does not automatically turn every product page into a well-cited page. |
| veterinary expert transparency | 8/10 | 15 | Public Nutramax news materials name Todd Henderson, DVM, as President and CEO. The quality-audit announcement also names Godwin Omorogieva as Vice President of Quality. These identify people and their disclosed company roles, although they are found in media material rather than a consolidated expert page. Executive leadership is the role verified for Henderson; it is not proof he formulated or reviewed each product. Omorogieva is named with a role, but no professional credential is inferred. |
| testing coa transparency | 7/10 | 15 | The public quality process distinguishes raw-material analytical chemistry and microbiology, internal raw-material COAs, in-process checks, finished-product testing in Nutramax chemistry/microbiology laboratories and stability testing. These are specific testing disclosures. The reviewed quality, product and media sources do not provide a purchaser-facing finished-product lot-to-COA lookup or an enumerated contaminant panel with batch results. This finite finding does not establish that testing or COAs do not exist. A facility auditor is not treated as the product-testing laboratory. |
| manufacturing quality system transparency | 9/10 | 10 | Nutramax identifies owned manufacturing in Lancaster, South Carolina; product contact information supplies the Quality Drive address. Its primary-navigation quality page explains supplier approval, incoming-material checks, cGMP/SOPs and production controls. The May 26, 2022 announcement identifies a UL-administered independent GMP conformance assessment. The reviewed public sources do not supply current audit scope or renewal details, or complete ingredient-origin traceability. The 2022 announcement is historical disclosure; this does not establish that current certification or sourcing records are absent. |
| claim discipline consumer honesty | 8/10 | 10 | The sampled product pages primarily use support language and attach survey attribution to veterinarian-recommendation statements. Some research/combination wording is more categorical than the study identification supplied beside it, particularly on Dasuquin and Proviable. This is a sampled disclosure assessment. Survey raw data, every historical advertisement and the clinical substantiation for every support claim were not audited. A study-access gap is not a finding that the advertised benefit is false. |
| accessibility buyer verifiability | 7/10 | 10 | Quality and manufacturing explanations are linked from corporate navigation. Product facts and some references are public across the product domains. Named leadership appears in media material, and additional research is accessible through public journals. Finding the whole record requires moving between product domains, media pages and journal sources; it is not all assembled in a single buyer evidence hub. Professional access is not the only route to all studies. |
Sources reviewed through 11 November 2026. Representative US product-family sample: Cosequin US chewable tablets with MSM; Dasuquin US With MSM soft chews, both size formulas; Denamarin US chewable tablets for dogs; Proviable US DC capsules; Welactin US Advanced3TA liquid for dogs,2mL scoop. Dasuquin Senior checked separately for variation. This is not a census of every SKU.
n-cosequin; n-dasuquin; n-dasuquin-about; n-dasuquin-trial; n-denamarin-about; n-denamarin-label; n-media; n-proviable-label; n-proviable-study; n-quality; n-senior; n-story; n-ul; n-welactin
Frequently asked questions
What did this Nutramax review correct?
Correction notice — 11 November 2026: the earlier review omitted Nutramax’s May 26, 2022 disclosure of a UL-administered GMP assessment and wrongly implied that the relevant clinical evidence was inaccessible to consumers. We have corrected those statements, added public research references, narrowed claims about COA access and removed unsupported blanket claims about experts and catalogue-wide disclosures. The revised score is 74.5/100 under the published criteria.
Does Nutramax disclose an independent audit?
Nutramax describes internal raw-material and finished-product testing. A May 26, 2022 company announcement reports an independent GMP conformance assessment administered by UL. That announcement documents the audit reported then; it does not establish current certificate validity or identify the analytical laboratory for any particular finished-product lot.
Does this establish current certification?
No. The linked announcement reports the assessment disclosed on May 26, 2022. This review has not established the present validity and scope of a current certificate.
Does Nutramax test its products?
Nutramax’s public quality description says it tests raw materials and finished products internally. The 2022 announcement adds independent manufacturing-audit context. This review should not have described the complete quality system as entirely self-attested.
Did this review inspect a lot-specific COA?
The product and quality sources linked here did not provide a public, lot-matched finished-product certificate of analysis for us to inspect in this review. That limits this review of batch documentation; it is not evidence that Nutramax does not test, that a certificate does not exist, or that another product is safer.
Is Nutramax research inaccessible to consumers?
Public research can be read without a Nutramax professional login. For example, Hart and colleagues (2012) evaluated Proviable-DC in 53 cats with chronic diarrhea over 21 days. Owners reported firmer stools, but this was an open-label study without a placebo control. It establishes the existence of accessible product-specific research; it does not prove all claims for all Proviable formulations.
Does a product study establish every benefit?
No. The conclusion depends on the studied formulation, dose, species, population, controls and endpoint. Studies of one product do not establish every claim across a brand catalogue.
Do Nutramax labels disclose quantities?
The reviewed Cosequin with MSM tablet, Dasuquin with MSM soft chews, Dasuquin Senior soft chews and Welactin Advanced 3TA liquid publish quantities. The panels differ by product and, for Dasuquin, size variant. Senior’s total-only blend is a specific limitation, not an absence of quantities. The linked product comparisons preserve units and qualifications such as ASU powder standardization.
What happened to the numeric transparency score?
The revised public-disclosure score is 74.5/100, calculated from all eight published criteria. The dated source sample and criterion reasons are recorded in the report dataset. This score is not a safety or effectiveness rating.
Does this review rank Nutramax’s safety or effectiveness?
No. It describes identified public disclosures and their limits. It is not a laboratory assessment or a catalogue-wide clinical comparison.
Where can I review the scoring calculation?
The revised public-disclosure score is 74.5/100, calculated from all eight published criteria. The dated source sample and criterion reasons are recorded in the report dataset. This score is not a safety or effectiveness rating.
Should a La Petite Labs product replace a recommended Nutramax product?
A joint-support product, a liver-support product, a probiotic and an omega-3 product serve different purposes. Our separate comparisons discuss specific formulations; this brand review does not recommend a La Petite Labs replacement for a veterinarian-directed Nutramax product. La Petite Labs’ labels and benefit claims require the same scrutiny.
Sources checked
Reviewed on 10 November 2026. Manufacturer pages document what the manufacturer discloses. Published research must be read for formulation, methods, outcomes and limitations.
- Nutramax quality process — Raw-material and finished-product testing descriptions.
- Nutramax UL GMP audit announcement (May 26, 2022) — Historical independent-audit disclosure; current validity not verified.
- Hart et al. (2012), open-label Proviable-DC study in cats — Accessible study with design and outcome limitations.
- Kampa et al. (2023), dog hip-osteoarthritis trial — Methods identify Dasuquin with MSM; limited to tested formulation and outcomes.
- Kampa et al. funding corrigendum — Corrects funder to Pharmalink International.
- Cosequin Chewable Tablets with MSM — Exact US product scope and label panel, checked 2026-11-10
- Dasuquin With MSM Soft Chews — Exact US product scope and label panel, checked 2026-11-10
- Dasuquin Soft Chews for Senior Dogs — Exact US product scope and label panel, checked 2026-11-10
- Welactin Advanced 3TA Omega-3 Supplement for Dogs — Exact US product scope and label panel, checked 2026-11-10






